Asset overview
Program snapshot
Target: Unknown
Cell type: NK_CELL
Indications: Advanced Hepatocellular Carcinoma
Sponsor: Shantou University Medical College
Institution: Shantou University Medical College
Car Nk
SZ003 CAR-NK
SZ003 CAR-NK is flagged as a platform signal because it has an active early-phase oncology cell-therapy trial at Shantou University Medical College, with a possible patent signal linked through modality_match. Manual review is still required.
Clinical evidence
Trial footprint
Phase: Na
Status: Terminated
Trial count: 1
Active trials: 0
First posted: May 6, 2023
Last updated: January 29, 2025
Signal summary
IP and BD posture
IP signal: Possible
BD label: Platform Signal
Confidence: Medium
Manual review required: Yes
Scores
Deterministic scoring
Clinical translation1
IP linkage3
Licensing clarity3
Strategic interest2
Source
Public trial record
Review the underlying ClinicalTrials.gov record and treat Treelip output as a prioritization layer, not a final diligence conclusion.
NCT IDs: NCT05845502